Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Novartis Pharmaceuticals
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Histologically documented adenocarcinoma of the prostate.
You may not be if
Patients who have undergone medical castration must continue Luteinizing hormone-releasing hormone (LHRH) agonist or antagonist therapy during study treatment
Patients must be able to provide written informed consent
Patients with prior or concurrent brain metastases
Impaired cardiac, gastrointestinal, kidney, or liver function
